These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 39297377)

  • 1. Extracellular vesicle and CRISPR gene therapy: Current applications in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and Huntington's disease.
    Akyuz E; Aslan FS; Gokce E; Ilmaz O; Topcu F; Kakac S
    Eur J Neurosci; 2024 Oct; 60(8):6057-6090. PubMed ID: 39297377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Delivery for Neurodegenerative Disorders Using Gene Therapy Vectors: Gene Next Therapeutic Goals.
    Singh M; Singh SP; Yadav D; Agarwal M; Agarwal S; Agarwal V; Swargiary G; Srivastava S; Tyagi S; Kaur R; Mani S
    Curr Gene Ther; 2021; 21(1):23-42. PubMed ID: 32811395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next Generation Precision Medicine: CRISPR-mediated Genome Editing for the Treatment of Neurodegenerative Disorders.
    Raikwar SP; Kikkeri NS; Sakuru R; Saeed D; Zahoor H; Premkumar K; Mentor S; Thangavel R; Dubova I; Ahmed ME; Selvakumar GP; Kempuraj D; Zaheer S; Iyer SS; Zaheer A
    J Neuroimmune Pharmacol; 2019 Dec; 14(4):608-641. PubMed ID: 31011884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale.
    Ruffini N; Klingenberg S; Schweiger S; Gerber S
    Cells; 2020 Dec; 9(12):. PubMed ID: 33302607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Based Genome-Editing Tools for Huntington's Disease Research and Therapy.
    Qin Y; Li S; Li XJ; Yang S
    Neurosci Bull; 2022 Nov; 38(11):1397-1408. PubMed ID: 35608753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9 novel therapeutic road for the treatment of neurodegenerative diseases.
    Karimian A; Gorjizadeh N; Alemi F; Asemi Z; Azizian K; Soleimanpour J; Malakouti F; Targhazeh N; Majidinia M; Yousefi B
    Life Sci; 2020 Oct; 259():118165. PubMed ID: 32735884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of CRISPR-Cas9 in Alzheimer's Disease and Related Disorders.
    De Plano LM; Calabrese G; Conoci S; Guglielmino SPP; Oddo S; Caccamo A
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential of gene editing for Huntington's disease.
    Duan W; Urani E; Mattson MP
    Trends Neurosci; 2023 May; 46(5):365-376. PubMed ID: 36907678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling Molecular and Genetic Insights into Neurodegenerative Diseases: Advances in Understanding Alzheimer's, Parkinson's, and Huntington's Diseases and Amyotrophic Lateral Sclerosis.
    Ciurea AV; Mohan AG; Covache-Busuioc RA; Costin HP; Glavan LA; Corlatescu AD; Saceleanu VM
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNAs and Neurodegenerative Diseases.
    Qiu L; Tan EK; Zeng L
    Adv Exp Med Biol; 2015; 888():85-105. PubMed ID: 26663180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of the CRISPR-Cas9 Gene Editing System to Dissect Neuroinflammatory and Neuropharmacological Mechanisms in Parkinson's Disease.
    Luo J; Padhi P; Jin H; Anantharam V; Zenitsky G; Wang Q; Willette AA; Kanthasamy A; Kanthasamy AG
    J Neuroimmune Pharmacol; 2019 Dec; 14(4):595-607. PubMed ID: 30879240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Age-Related Neurodegenerative Diseases by AAV-Mediated Gene Therapy.
    Cagin U
    Adv Exp Med Biol; 2021; 1286():213-223. PubMed ID: 33725356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone Methylation Regulation in Neurodegenerative Disorders.
    Basavarajappa BS; Subbanna S
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use of Stem Cells as a Potential Treatment Method for Selected Neurodegenerative Diseases: Review.
    Cecerska-Heryć E; Pękała M; Serwin N; Gliźniewicz M; Grygorcewicz B; Michalczyk A; Heryć R; Budkowska M; Dołęgowska B
    Cell Mol Neurobiol; 2023 Aug; 43(6):2643-2673. PubMed ID: 37027074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9 Mediated Therapeutic Approach in Huntington's Disease.
    Alkanli SS; Alkanli N; Ay A; Albeniz I
    Mol Neurobiol; 2023 Mar; 60(3):1486-1498. PubMed ID: 36482283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of connexins in neurodegenerative diseases (Review).
    Xing J; Xu C
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo genome editing improves motor function and extends survival in a mouse model of ALS.
    Gaj T; Ojala DS; Ekman FK; Byrne LC; Limsirichai P; Schaffer DV
    Sci Adv; 2017 Dec; 3(12):eaar3952. PubMed ID: 29279867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neural stem cell-based treatment for neurodegenerative diseases.
    Kim SU; Lee HJ; Kim YB
    Neuropathology; 2013 Oct; 33(5):491-504. PubMed ID: 23384285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene Therapy, A Novel Therapeutic Tool for Neurological Disorders: Current Progress, Challenges and Future Prospective.
    Iqubal A; Iqubal MK; Khan A; Ali J; Baboota S; Haque SE
    Curr Gene Ther; 2020; 20(3):184-194. PubMed ID: 32674730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodegenerative Disorders Treatment: The MicroRNA Role.
    Ridolfi B; Abdel-Haq H
    Curr Gene Ther; 2017; 17(5):327-363. PubMed ID: 29357791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.